Literature DB >> 31970238

Duodenal Crohn's Disease Complicated by Pancreatitis and Common Bile Duct Obstruction.

Mafalda Sousa1, Luísa Proença1, João Carlos Silva1, Ana Catarina Ribeiro Gomes1, Edgar Afeto1, João Carvalho1.   

Abstract

INTRODUCTION: Crohn's disease (CD) is characterized by segmental and transmural involvement of any portion of the gastrointestinal tract from the mouth to the anus. Duodenal CD is a rare clinical entity, with the majority of the patients being symptomless - its diagnosis requires a high level of clinical suspicion. CASE
PRESENTATION: We present the case of a 29-year-old male patient with a 2-month history of weight loss, epigastric pain and postprandial vomiting. He underwent upper endoscopy, which revealed a circumferential duodenal ulcer causing non-transposable luminal stenosis and was medicated with proton pump inhibitors. While awaiting gastroenterology consultation, he presented at the emergency department for sudden onset of abdominal pain with dorsal irradiation, nausea and vomiting. Laboratory tests showed anaemia and increased liver enzymes, amylase and lipase. Abdominal computed tomography showed ectasia of the common bile duct (CBD) and intrahepatic biliary tract and a small amount of gas in the main pancreatic duct associated with duodenal thickening. The case was interpreted as probable CD complicated by pancreatitis and obstruction of the CBD, and he was hospitalized under antibiotic therapy and hydrocortisone with improvement of the condition. After discharge, he underwent colonoscopy that revealed several ulcers in the ileum and magnetic resonance imaging that showed distension of the stomach with reduction of the calibre of the transition from the duodenal bulb to the second portion of the duodenum in a 10- to 15-mm extension, as well as associated dilatation of the intrahepatic bile ducts and CBD and diffuse and regular ectasia of the main pancreatic duct. Combination therapy with azathioprine and infliximab was initiated; the patient presented clinical response at 12 weeks and endoscopic/imaging remission at 9 months. DISCUSSION/
CONCLUSION: Hepatobiliary and pancreatic manifestations are common in CD patients involving multiple mechanisms. In this case report, we pre-sent a patient with duodenal CD complicated with pancreatitis and CBD obstruction due to distortion phenomena by duodenal stenosis, a condition that is rarely described.
Copyright © 2019 by S. Karger AG, Basel.

Entities:  

Keywords:  Common bile duct obstruction; Duodenal Crohn's disease; Pancreatitis

Year:  2019        PMID: 31970238      PMCID: PMC6959094          DOI: 10.1159/000499767

Source DB:  PubMed          Journal:  GE Port J Gastroenterol        ISSN: 2387-1954


  5 in total

1.  Acute pancreatitis in patients with Crohn's disease: clinical features and outcomes.

Authors:  Picha Moolsintong; Edward V Loftus; Suresh T Chari; Laurence J Egan; William J Tremaine; William J Sandborn
Journal:  Inflamm Bowel Dis       Date:  2005-12       Impact factor: 5.325

Review 2.  Duodenal Crohn's Disease.

Authors:  Amy L Lightner
Journal:  Inflamm Bowel Dis       Date:  2018-02-15       Impact factor: 5.325

Review 3.  Hepatobiliary manifestations in inflammatory bowel disease: the gut, the drugs and the liver.

Authors:  María Rojas-Feria; Manuel Castro; Emilio Suárez; Javier Ampuero; Manuel Romero-Gómez
Journal:  World J Gastroenterol       Date:  2013-11-14       Impact factor: 5.742

4.  Crohn's disease with gastroduodenal involvement: Diagnostic approach.

Authors:  Sachin B Ingle; Baban D Adgaonkar; Nawab P Jamadar; Saleha Siddiqui; Chitra R Hinge
Journal:  World J Clin Cases       Date:  2015-06-16       Impact factor: 1.337

5.  3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn's Disease 2016: Part 1: Diagnosis and Medical Management.

Authors:  Fernando Gomollón; Axel Dignass; Vito Annese; Herbert Tilg; Gert Van Assche; James O Lindsay; Laurent Peyrin-Biroulet; Garret J Cullen; Marco Daperno; Torsten Kucharzik; Florian Rieder; Sven Almer; Alessandro Armuzzi; Marcus Harbord; Jost Langhorst; Miquel Sans; Yehuda Chowers; Gionata Fiorino; Pascal Juillerat; Gerassimos J Mantzaris; Fernando Rizzello; Stephan Vavricka; Paolo Gionchetti
Journal:  J Crohns Colitis       Date:  2016-09-22       Impact factor: 9.071

  5 in total
  1 in total

1.  Adalimumab for induction of remission in patients with Crohn's disease: a systematic review and meta-analysis.

Authors:  Juntao Yin; Yang Li; Yangyang Chen; Chaoyang Wang; Xiaoyong Song
Journal:  Eur J Med Res       Date:  2022-09-30       Impact factor: 4.981

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.